Eli Lilly’s Retatrutide Shows Strong Weight Loss, Nears Diabetes Approval
Retatrutide’s Triple Action Targets Metabolism Eli Lilly’s retatrutide drug is making waves in the metabolic health field. It…
Life Biosciences lands $80m to push cell reset therapy
Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
City dementia research nurse ‘one of UK’s first’
One of the country’s first nurses dedicated to dementia research has been appointed in Sheffield to help build…
Why clinical trials on nutritional supplements are hard to design
Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
Klothea initiates longevity-focused human trial of klotho therapy
Recruitment for Phase 1 trial of mRNA therapy begins in ‘special economic zone’ on the Caribbean island of…
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1Remibrutinib,…
Fact Check Team: GLP-1 users getting rare pirate disease
WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals – Endpoints News
Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways stock soars after…
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Disc Medicine Inc FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and…
FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…
Juvena lands $33.5m to advance more regenerative biologics to the clinic
Co-founder Hanadie Yousef to step down as CEO as company gears up for more clinical trials of drugs…